Schwameis Michael, Schober Andreas, Schörgenhofer Christian, Sperr Wolfgang Reinhard, Schöchl Herbert, Janata-Schwatczek Karin, Kürkciyan Erol Istepan, Sterz Fritz, Jilma Bernd
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria. 2Department of Emergency Medicine, Medical University of Vienna, Vienna, Austria. 3Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria. 4Department of Anaesthesiology and Intensive Care Medicine, AUVA Trauma Centre Salzburg, Salzburg, Austria.
Crit Care Med. 2015 Nov;43(11):2394-402. doi: 10.1097/CCM.0000000000001273.
To date, no study has systematically investigated the impact of drowning-induced asphyxia on hemostasis. Our objective was to test the hypothesis that asphyxia induces bleeding by hyperfibrinolytic disseminated intravascular coagulation.
Observational study.
A 2,100-bed tertiary care facility in Vienna, Austria, Europe.
All cases of drowning-induced asphyxia (n=49) were compared with other patients with cardiopulmonary resuscitation (n=116) and to patients with acute promyelocytic leukemia (n=83). Six drowning victims were investigated prospectively. To study the mechanism, a forearm-ischemia model was used in 20 volunteers to investigate whether hypoxia releases tissue plasminogen activator.
None.
Eighty percent of patients with drowning-induced asphyxia developed overt disseminated intravascular coagulation within 24 hours. When compared with nondrowning cardiac arrest patients, drowning patients had a 13 times higher prevalence of overt disseminated intravascular coagulation at admission (55% vs 4%; p<0.001). Despite comparable disseminated intravascular coagulation scores, acute promyelocytic leukemia patients had higher fibrinogen but lower d-dimer levels and platelet counts than drowning patients (p<0.001). Drowning victims had a three-fold longer activated partial thromboplastin time (124 s; p<0.001) than both nondrowning cardiac arrest and acute promyelocytic leukemia patients. Hyperfibrinolysis was reflected by up to 1,000-fold increased d-dimer levels, greater than 5-fold elevated plasmin antiplasmin levels, and a complete absence of thrombelastometric clotting patterns, which was reversed by antifibrinolytics and heparinase. Thirty minutes of forearm-ischemia increased tissue plasminogen activator 31-fold (p<0.001).
The vast majority of drowning patients develops overt hyperfibrinolytic disseminated intravascular coagulation, partly caused by hypoxia induced tissue plasminogen activator release. Antifibrinolytics and heparinase partially reverse the abnormal clotting patterns. Severe activated partial thromboplastin time prolongation may be a marker of combined hyperfibrinolytic afibrinogenemia and autoheparinization in drowning-related asphyxia.
迄今为止,尚无研究系统地调查溺水所致窒息对止血功能的影响。我们的目的是检验窒息通过高纤维蛋白溶解型弥散性血管内凝血导致出血的假说。
观察性研究。
欧洲奥地利维也纳一家拥有2100张床位的三级医疗机构。
将所有溺水所致窒息病例(n = 49)与其他接受心肺复苏的患者(n = 116)以及急性早幼粒细胞白血病患者(n = 83)进行比较。对6名溺水受害者进行了前瞻性研究。为研究其机制,在20名志愿者中使用前臂缺血模型来调查缺氧是否会释放组织纤溶酶原激活物。
无。
80%的溺水所致窒息患者在24小时内发生明显的弥散性血管内凝血。与非溺水心脏骤停患者相比,溺水患者入院时明显弥散性血管内凝血的患病率高13倍(55%对4%;p < 0.001)。尽管弥散性血管内凝血评分相当,但急性早幼粒细胞白血病患者的纤维蛋白原水平较高,而D - 二聚体水平和血小板计数低于溺水患者(p < 0.001)。溺水受害者的活化部分凝血活酶时间比非溺水心脏骤停患者和急性早幼粒细胞白血病患者长三倍(124秒;p < 0.001)。高纤维蛋白溶解表现为D - 二聚体水平升高高达1000倍、纤溶酶 - 抗纤溶酶水平升高超过5倍以及完全没有血栓弹力图凝血模式,抗纤溶剂和肝素酶可使其逆转。30分钟的前臂缺血使组织纤溶酶原激活物增加31倍(p < 0.001)。
绝大多数溺水患者发生明显高纤维蛋白溶解型弥散性血管内凝血,部分原因是缺氧诱导组织纤溶酶原激活物释放。抗纤溶剂和肝素酶可部分逆转异常凝血模式。严重的活化部分凝血活酶时间延长可能是溺水相关窒息中高纤维蛋白溶解型无纤维蛋白原血症和自身肝素化合并存在的一个标志。